He regularly represents clients before U.S. federal and state financial regulatory authorities, including the U.S. Securities and Exchange Commission and the Financial Industry Regulatory Authority. He also represents clients in filing comment letters and amicus briefs in connection with SEC rulemakings.
Deep Dive Episode 168 – Deepfakes: What, If Anything, Should Policymakers Do?
Joshua Abbott, Robert Chesney, Kathryn Ciano Mauler, Matthew Feeney
“Deepfakes” are one of the latest technologies to prompt debate about online media. Using Deepfake...
Deep Dive Episode 166 – The CFPB Taskforce Report on Federal Consumer Financial Law
David Silberman, Todd J. Zywicki, Brian C. Johnson
Recent years have seen a dramatic shift in the way in which American consumers use...
Deep Dive Episode 164 – How Will the Biden Administration Handle China's Intellectual Property Practices?
Mark Cohen, Justin Hughes, Brian O'Shaughnessy
The Biden administration faces a variety of issues when it comes to China, from trade...
Deep Dive Episode 160 – The Myths and Facts Regarding the EPA’s Benefit-Cost Analysis and Science Transparency Rules
Rachel Jones, Clint Woods, Daren Bakst
The Environmental Protection Agency recently finalized two new transparency-related rules. The stated purpose of the...
Deep Dive Episode 159 – Countering the Politicization of Financial Services: Is the Cure Worse than the Disease?
John Berlau, C. Wallace DeWitt, Brian Knight
In several recent high-profile cases, banks have conditioned or denied financial services to disfavored industries after...
Deep Dive Episode 158 – Courthouse Steps Oral Arguments: AMG Capital Management v. FTC
Alden F. Abbott, Corbin K. Barthold, Asheesh Agarwal
On January 13, the Supreme Court heard oral argument in AMG Capital Management v. FTC, a...
Deep Dive Episode 157 – Regulating Land Use During a Pandemic
Yonah Freemark, Emily Hamilton, Luke A. Wake
The COVID-19 pandemic has caused significant changes in urban land use. Where possible, companies have...
Deep Dive Episode 156 – Incentivizing Drug Development: Patents or Prizes?
David Hyman, Adam Mossoff, Brian O'Shaughnessy
Medical innovation has made modern life miraculous by historical standards, as demonstrated by the unprecedented...
Deep Dive Episode 155 – International Reference Pricing and Negotiation: Yes or No?
Adam Mossoff, Wendell Primus, Dean Reuter
Drug prices are a pressing policy issue. On November 20, 2020, President Donald Trump announced two new...
Deep Dive Episode 154 – Tech Policy Under the Biden Administration and 117th Congress
Jennifer Huddleston, Blake Reid, Adam Thierer
In this episode, an expert panel looks at what the new year may bring regarding the...